Tiziana Life Sciences reported encouraging brain inflammation findings in its MSA study, strengthening attention on ...
Microsoft's new vulnerability-scanning system, codenamed MDASH, scored 88.45% on the CyberGym benchmark, surpassing ...
Foralumab is the first intranasal immune modulator in clinical trials for patients with Multiple System AtrophyBOSTON, May 14, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ...
Detailed price information for Alterity Therapeutics Ltd ADR (ATHE-Q) from The Globe and Mail including charting and trades.
Detailed price information for Alterity Therapeutics Ltd (PRNAF) from The Globe and Mail including charting and trades.
AI does not create atrophy on its own. Passive organizations and poorly designed systems do. When companies insert AI into ...
Peer-reviewed study from the bioMUSE Natural History Study shows advanced MRI method detects disease-specific iron accumulation that supports diagnosis and correlates with clinical severity in ...
Publication of a peer-reviewed study from Alterity Therapeutic’s bioMUSE study shows an advanced MRI imaging method detects ...
Alterity Therapeutics is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases. The Company is focused on developing ...
Alignment reached on chemistry, manufacturing, and control (CMC) elements of ATH434 Phase 3 development program – – Positive feedback supports ...
Astronomers at The University of New Mexico have published new research confirming three bodies orbiting the dynamic exoplanet system TOI-201. They include a super-Earth (TOI-201 d), a warm Jupiter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results